Avid Bioservices Names Nicholas Green as President and Chief Executive OfficerGlobeNewsWire • 06/23/20
Analysts Estimate Avid Bioservices (CDMO) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 06/18/20
Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial ManufacturingGlobeNewsWire • 05/06/20
Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and AsiaGlobeNewsWire • 04/13/20
Avid Bioservices, Inc. (CDMO) CEO Richard Hancock on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/11/20
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred StockGlobeNewsWire • 03/04/20
Will Avid Bioservices (CDMO) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 03/02/20
Avid Bioservices, Inc. (CDMO) CEO Rick Hancock on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 12/10/19
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent DevelopmentsGlobeNewsWire • 12/09/19
Avid Bioservices - Declares Quarterly Dividend on Its Series E Convertible Preferred StockGlobeNewsWire • 12/04/19
Avid Bioservices (CDMO) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 12/02/19
Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory InfrastructureGlobeNewsWire • 10/08/19
Avid Bioservices, Inc. (CDMO) CEO Rick Hancock on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 09/06/19